News Focus
News Focus
Followers 19
Posts 817
Boards Moderated 0
Alias Born 12/12/2016

Re: falconer66a post# 130402

Tuesday, 11/14/2017 11:56:48 AM

Tuesday, November 14, 2017 11:56:48 AM

Post# of 516951
Excellent post, as usual, Falconer. And as Mikesc has kindly pointed out, the well respected medical journalist, Michelle Sullivan, is expected to publish her interview (from yesterday) with Dr Missling sometime today.

Based upon her favorable article from back in FEBRUARY 2017 (link below) regarding the a2-73 safety and efficacy through 57 weeks, I’m curious how she will report on the 109 week IMPROVEMENT/STABILIZATION seen in our Alzheimer’s patients (as correlated to dose/blood concentration per Ariana analysis).

I’m still struggling to find the negatives regarding this Company and its unique and seemingly EFFECTIVE MOA. I’ll keep looking.


http://www.mdedge.com/neurologyreviews/article/130412/alzheimers-cognition/can-sigma-1-agonist-stabilize-cognition-and

“Can a Sigma-1 Agonist Stabilize Cognition and Function in Alzheimer’s Disease?
A novel drug appeared to benefit patients in a phase IIa trial.”

Neurology Reviews. 2017 February;25(2):46
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News